Innoviva, Inc. (INVA)
CIK 1080014 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 72.2M shares as of Jul 31, 2026 (10-Q).
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 0 underlying shares, as reported Dec 31, 2025 (10-K).
Reported exercise price: $18.11 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 72.2M = 72.2M O/S + 0 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Two Thousand Twenty Eight Notes | $261.0M | — | $26.22 | 2.125% | ~10.0M sh |
| Syndeio Two Thousand Twenty One Convertible Note | $66.5M | $1.1M | not tagged | — | — |
| Syndeio Two Thousand Twenty Five Convertible Note | $25.8M | $27.0M | not tagged | — | — |
| Convertible Promissory Note | $9.2M | — | not tagged | — | — |
If every note above converted at its tagged price: ~10.0M new shares on 72.2M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 5, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 72.2M | Jul 31, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 0 | Dec 31, 2025 |
| + Two Thousand Twenty Eight Notes (if fully converted) | 10.0M | Mar 31, 2022 |
| Fully diluted estimate | 82.2M | +13.8% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 0 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full INVA workspace